INBX — Inhibrx Biosciences

Median target
$237.5
calls from the last 12 months
Implied return
+192.9%
median target vs. price
Coverage
2 analysts · 2 calls
updated in the last 12 months
Consensus
2/0/0+2 net
Buy / Hold / Sell

Which analysts are behind INBX's consensus?

See every current rating, price target and the analysts' track records for Inhibrx Biosciences — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 2 analysts with calls on INBX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

INBX elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-10-14InsidersLappe MarkChief Executive OfficerInsider purchase2.5K sh @ $85.00$210K
2026-10-14InsidersLappe MarkChief Executive OfficerInsider purchase2.5K sh @ $85.00$208K
2026-10-14InsidersLappe MarkChief Executive OfficerInsider purchase2.5K sh @ $84.07$208K
2026-10-14InsidersLappe MarkChief Executive OfficerInsider purchase2.4K sh @ $84.07$206K
2026-10-14InsidersLappe MarkChief Executive OfficerInsider purchase100 sh @ $85.76$9K
2026-10-14InsidersLappe MarkChief Executive OfficerInsider purchase100 sh @ $85.76$9K
2026-09-28InsidersLappe MarkDirector,OfficerInsider purchase3.0K sh @ $101.70$305K
2026-09-28InsidersLappe MarkDirector,OfficerInsider purchase1.5K sh @ $98.88$148K
2026-09-25InsidersLappe MarkDirector,OfficerInsider purchase3.3K sh @ $98.87$329K
2026-09-25InsidersLappe MarkDirector,OfficerInsider purchase2.2K sh @ $99.60$217K

More: insider activity · executive branch · trending